-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pulmonary_hi_impact.pdf
April 01, 2012 - PULMONARY with "Discussions" in Exec Summary
AHRQ Healthcare Horizon Scanning System – Potential High
Impact Interventions Report
Priority Area 13: Pulmonary Disease including Asthma
Potential High Impact Interventions Report
Prepared for:
Agency for Healthcare Research and Quality
U.S. Departmen…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0398_06-17-2008.pdf
January 01, 2008 - subgroups of
hemodialysis patients treated with erythropoiesis stimulating agents (ESA), or with ESA
resistance
-
effectivehealthcare-admin.ahrq.gov/products/mhs4-opioid-stewardship/rapid-research
December 01, 2023 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/products/mhs4-computerized-cds/rapid-research
February 01, 2024 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/products/c-difficile-future/research
December 01, 2019 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/healthcare-infections_research-protocol.pdf
January 01, 2014 - ECRI_Penn EPC FINAL Environ Cleaning Protocol 08_21_14 CC[1]
Source: www.effectivehealthcare.ahrq.gov
Published online: August 25. 2014
Evidence-based Practice Center
Technical Brief Protocol
Project Title: Environmental Cleaning for the Prevention of Healthcare-Associated
Infections (HAI)
I. Background …
-
effectivehealthcare-admin.ahrq.gov/products/patient-safety-telehealth/research
September 01, 2023 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/fiber-intake-draft-report-appendix-a-b.pdf
February 25, 2025 - Template for Reports Developed
B-1
Appendix A. Methods
A.1 Search Strategies
PubMed search strategy
((("cereal fiber"[tiab:~2] OR "cereal fibers" OR "cereal fibre"[tiab:~2] OR "cereal fibres" OR
((cereal OR edible OR whole) AND grain*) OR "soluble fiber*" OR "soluble fibre*" OR
"insoluble fiber*" OR "insolubl…
-
effectivehealthcare-admin.ahrq.gov/products/hepatitis-c-treatment-adherence/research-protocol
December 01, 2019 - interventions in improving intermediate (e.g., sustained viral response, histological changes, drug resistance … sustained viral response (SVR), histological response, biochemical response (i.e., ALT level), drug resistance … We will record authors’ definitions about SVR, drug resistance, histological response, and quality of … response
Early viral response
Sustained viral response
Disease relapse
Development of any viral resistance … interventions in improving intermediate (e.g. sustained viral response, histological changes, drug resistance
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-2007_executive.pdf
January 01, 2007 - Angiotensin II acts directly on the
resistance vessels to increase systemic vascular
resistance and arterial
-
effectivehealthcare-admin.ahrq.gov/products/hepatitis-c-screening/research
December 01, 2019 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/venous-ulcers-treatment_research-protocol.pdf
September 13, 2012 - Promotion of antibiotic resistance
c. Systemic absorption (rare)
3. … Promotion of antibiotic resistance
f. Selection of resistant organisms
4. … Adverse effects of treatment (KQs 1, 2, & 3)
Antibiotic-specific
Hypersensitivity
Antibiotic resistance … high bioavailability
GI intolerance; increased risk for C. diff;
prolonged exposure can result in resistance … hypersensitivity reactions, drug toxicity,
Clostridium difficile diarrhea, promotion of antibiotic resistance
-
effectivehealthcare-admin.ahrq.gov/products/depression-treatment-ssri/research-protocol
December 01, 2019 - TF populations may include patients who would meet criteria for treatment resistance ( > 2 inadequate … Treatment resistance is variably defined but usually refers to patients who have failed at least two … classified as having treatment resistant depression. 7 Similarly, there is the potential for pseudo-resistance
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/c-diff-infections_disposition-comments.pdf
March 01, 2012 - In the introduction no discussion was given regarding
review of strategies to improving patient's resistance … Text was added to elaborate on strategies to
improve resistance. … is a plausible biological mechanism to suggest that
vancomycin therapy for CDAD may not select for resistance … do
the authors mean by “resistant,” are they referring to in vitro the
clindamycin and quinolone resistance … or is there actual evidence of
resistance to the treating antibiotics or more that there is increased
-
effectivehealthcare-admin.ahrq.gov/products/antipsychotics-adults/research
December 01, 2019 - Subgroups
The most common subgroups were race and treatment resistance.
-
effectivehealthcare-admin.ahrq.gov/products/procalcitonin/research
December 01, 2019 - high interest for future research are the consequences of reduction in antibiotic use for antibiotic resistance
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/11_peptic_ulcer_potential_high_impact_2012-12-111.pdf
January 01, 2012 - PEPTIC ULCER #11
AHRQ Healthcare Horizon Scanning System – Potential
High-Impact Interventions Report
Priority Area 11: Peptic Ulcer Disease and Dyspepsia
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither Road
Rockville, MD 20850
ww…
-
effectivehealthcare-admin.ahrq.gov/products/venous-ulcers-treatment/research-protocol
December 01, 2019 - Hypersensitivity, contact dermatitis, and sensitization (e.g., neomycin)
Promotion of antibiotic resistance … peripherally inserted central catheter (PICC) line and access infections
Promotion of antibiotic resistance … high bioavailability
GI intolerance; increased risk for C. diff; prolonged exposure can result in resistance … contained in dressings: hypersensitivity, contact dermatitis, sensitization, promotion of antibiotic resistance … hypersensitivity reactions, drug toxicity, Clostridium difficile diarrhea, promotion of antibiotic resistance
-
effectivehealthcare-admin.ahrq.gov/products/hypertension-pulmonary-arterial/research-protocol
December 01, 2019 - pathological changes of the pulmonary microcirculation that lead to an increase in pulmonary vascular resistance … been found to contribute to changes in the pulmonary vasculature, causing increased pulmonary vascular resistance … This increased resistance, if unrelieved, progresses to right ventricular pressure overload, dysfunction … outcomes beyond pulmonary artery pressure to include hemodynamic parameters (e.g., pulmonary vascular resistance … Hemodynamic parameters such as pulmonary artery pressures (systolic, diastolic, and mean), vascular resistance
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/depression-treatment-ssri_research-protocol.pdf
June 15, 2010 - TF populations may include patients who would meet criteria for
treatment resistance (> 2 inadequate … Treatment resistance is variably defined but usually refers to patients who have failed at least
http … classified as having treatment resistant depression.7
Similarly, there is the potential for pseudo-resistance